| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.537 | 120.830 | 394.765 | 485.019 | 388.379 | 194.363 |
| Total Income - EUR | - | - | - | - | 6.813 | 131.885 | 397.631 | 488.749 | 392.702 | 197.276 |
| Total Expenses - EUR | - | - | - | - | 12.366 | 110.376 | 348.819 | 482.795 | 374.945 | 234.481 |
| Gross Profit/Loss - EUR | - | - | - | - | -5.553 | 21.510 | 48.812 | 5.954 | 17.757 | -37.205 |
| Net Profit/Loss - EUR | - | - | - | - | -5.689 | 19.392 | 45.465 | 1.794 | 14.134 | -37.205 |
| Employees | - | - | - | - | 0 | 2 | 2 | 4 | 0 | 3 |
Check the financial reports for the company - Orange Valley Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 21.862 | 62.959 | 63.879 | 52.617 |
| Current Assets | - | - | - | - | 2.246 | 52.793 | 78.797 | 334.392 | 343.759 | 310.847 |
| Inventories | - | - | - | - | 1.776 | 11.518 | 43.604 | 149.711 | 163.129 | 156.369 |
| Receivables | - | - | - | - | 340 | 40.534 | 24.563 | 142.539 | 169.614 | 138.893 |
| Cash | - | - | - | - | 130 | 741 | 10.630 | 42.143 | 11.016 | 15.585 |
| Shareholders Funds | - | - | - | - | -5.647 | 13.853 | 59.010 | 245.419 | 233.720 | 188.007 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 53.229 | 53.068 | 52.771 |
| Debts | - | - | - | - | 7.892 | 38.940 | 41.649 | 151.932 | 173.918 | 175.456 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1032 - 1032" | |||||||||
| CAEN Financial Year |
1032
|
|||||||||
Comments - Orange Valley Bio S.r.l.